Immediate Impact
71 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Crohn's disease
2024 Standout
Works of Sibylle Ritzmann being referenced
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis.
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sibylle Ritzmann | 198 | 82 | 173 | 4 | 315 | |
| Katia Seymons | 201 | 92 | 195 | 6 | 358 | |
| Milène K. Crispin | 192 | 113 | 190 | 6 | 328 | |
| Colin Clark | 133 | 51 | 213 | 5 | 309 | |
| Nazila Barahmani | 214 | 51 | 175 | 6 | 261 | |
| Hope Dinh | 119 | 92 | 116 | 7 | 301 | |
| C.E. Duarte Williamson | 211 | 56 | 244 | 4 | 356 | |
| R. Davis | 204 | 146 | 171 | 2 | 316 | |
| Ian C. Boothby | 38 | 9 | 62 | 5 | 323 | |
| Mélanie Berta | 36 | 10 | 66 | 5 | 343 | |
| Daniela Nitoiu | 19 | 21 | 29 | 5 | 262 |
All Works
Loading papers...